These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 26370363)

  • 1. Successful Treatment of Intractable Fluid Retention Using Tolvaptan After Treatment for Postoperative Mediastinitis in a Patient With a Left Ventricular Assist Device.
    Kimura M; Nawata K; Kinoshita O; Hatano M; Imamura T; Kinugawa K; Ono M
    Int Heart J; 2015; 56(5):574-7. PubMed ID: 26370363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful treatment of pump pocket infection after left ventricular assist device implantation by negative pressure wound therapy and omental transposition.
    Kimura M; Nishimura T; Kinoshita O; Okada S; Inafuku H; Kyo S; Ono M
    Ann Thorac Cardiovasc Surg; 2014; 20 Suppl():842-5. PubMed ID: 23535582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination of Urinary Sodium/Creatinine Ratio and Plasma Brain Natriuretic Peptide Level Predicts Successful Tolvaptan Therapy in Patients With Heart Failure and Volume Overload.
    Sato Y; Dohi K; Watanabe K; Tanimura M; Takeuchi T; Sugiura E; Sugimoto T; Kumagai N; Ogura T; Nakamori S; Fujimoto N; Yamada N; Ito M
    Int Heart J; 2016; 57(2):211-9. PubMed ID: 26973271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone-Induced Hyponatremia Masked by Tolvaptan in a Patient with an Implantable Left Ventricular Assist Device.
    Nakamura M; Sunagawa O; Kugai T; Kinugawa K
    Int Heart J; 2017 Dec; 58(6):1004-1007. PubMed ID: 29151494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of hyponatremia by tolvaptan before left ventricular assist device implantation.
    Imamura T; Kinugawa K; Shiga T; Kato N; Endo M; Inaba T; Maki H; Hatano M; Yao A; Hirata Y; Nishimura T; Kyo S; Ono M; Nagai R
    Int Heart J; 2012; 53(6):391-3. PubMed ID: 23258142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
    Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
    Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-Term Efficacy and Safety of Tolvaptan in Patients with Left Ventricular Assist Devices.
    Fujino T; Imamura T; Nguyen A; Chung B; Raikhelkar J; Rodgers D; Nitta D; Smith B; Sarswat N; Kalantari S; Narang N; LaBuhn C; Jeevanandam V; Kim G; Sayer G; Uriel N
    ASAIO J; 2020 Mar; 66(3):253-257. PubMed ID: 31567410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omental flap for treatment of mediastinitis post-left ventricular assist device implantation.
    Rodriguez LE; Bruckner BA; Loebe M
    Artif Organs; 2013 Dec; 37(12):1081-2. PubMed ID: 24329547
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of left ventricular assist device (HeartMate II): a Singapore experience.
    Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
    Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracorporeal membrane oxygenation as perioperative right ventricular support in patients with biventricular failure undergoing left ventricular assist device implantation.
    Scherer M; Sirat AS; Moritz A; Martens S
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):939-44; discussion 944. PubMed ID: 21071240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiac autonomic dysfunction in the early phase after left ventricular assist device implant: Implications for surgery and follow-up.
    Compostella L; Russo N; Setzu T; Tursi V; Bottio T; Tarzia V; Compostella C; Covolo E; Livi U; Gerosa G; Sani G; Bellotto F
    Int J Artif Organs; 2013 Jun; 36(6):410-8. PubMed ID: 23645580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
    Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of tolvaptan on acute heart failure with hyponatremia--a randomized, double blind, controlled clinical trial.
    Shanmugam E; Doss CR; George M; Jena A; Rajaram M; Ramaraj B; Anjaneyan K; Kanagesh B
    Indian Heart J; 2016 Apr; 68 Suppl 1(Suppl 1):S15-21. PubMed ID: 27056648
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable left ventricular assist device. Approaching an alternative for end-stage heart failure. Implantable LVAD Study Group.
    McCarthy PM; James KB; Savage RM; Vargo R; Kendall K; Harasaki H; Hobbs RE; Pashkow FJ
    Circulation; 1994 Nov; 90(5 Pt 2):II83-6. PubMed ID: 7955290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative right ventricular assist device implantation technique for patients with perioperative right ventricular failure.
    Saeed D; Maxhera B; Kamiya H; Lichtenberg A; Albert A
    J Thorac Cardiovasc Surg; 2015 Mar; 149(3):927-32. PubMed ID: 25433641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Temporary right ventricular support following left ventricle assist device implantation: a comparison of two techniques.
    Noly PE; Kirsch M; Quessard A; Leger P; Pavie A; Amour J; Leprince P
    Interact Cardiovasc Thorac Surg; 2014 Jul; 19(1):49-55. PubMed ID: 24659551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemodynamic effects of tolvaptan, a vasopressin V2 receptor blocker, in patients with symptomatic heart failure and systolic dysfunction: an international, multicenter, randomized, placebo-controlled trial.
    Udelson JE; Orlandi C; Ouyang J; Krasa H; Zimmer CA; Frivold G; Haught WH; Meymandi S; Macarie C; Raef D; Wedge P; Konstam MA; Gheorghiade M
    J Am Coll Cardiol; 2008 Nov; 52(19):1540-5. PubMed ID: 19007589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cavoaortic shunt improves hemodynamics with preserved oxygen delivery in experimental right ventricular failure during left ventricular assist device therapy.
    Vikholm P; Schiller P; Johansson J; Hellgren L
    J Thorac Cardiovasc Surg; 2014 Feb; 147(2):625-31. PubMed ID: 23477692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopressin V2 receptor antagonist tolvaptan is effective in heart failure patients with reduced left ventricular systolic function and low blood pressure.
    Suzuki S; Yoshihisa A; Yamaki T; Sugimoto K; Kunii H; Nakazato K; Abe Y; Saito T; Ohwada T; Suzuki H; Saitoh S; Kubota I; Takeishi Y;
    Int Heart J; 2015; 56(2):213-8. PubMed ID: 25740399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.